{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:10:06Z","timestamp":1780495806624,"version":"3.54.1"},"reference-count":32,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:p>\n                    <jats:italic toggle=\"yes\">Background and Aims:<\/jats:italic>\n                    Little is known about how the expansion of opioid agonist therapy (OAT) and emergence of fentanyl in the illicit drug supply in North America has influenced non-fatal opioid overdose (NFOD) risk. Therefore, we sought to identify patterns of substance use and addiction treatment engagement (i.e., OAT, other inpatient or outpatient treatment) prior to NFOD, as well as the trends and correlates of each pattern among people who use drugs (PWUD) in Vancouver, Canada.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic toggle=\"yes\">Methods:<\/jats:italic>\n                    Data were derived from participants in three prospective cohorts of PWUD in Vancouver in 2009\u20132016. Observations from participants reporting opioid-related NFOD in the previous six months were included. A latent class analysis was used to identify classes based on substances used at the time of last NFOD and addiction treatment engagement in the month prior to the last NFOD. Multivariable generalized estimating equations estimated the correlates of each class membership.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic toggle=\"yes\">Results:<\/jats:italic>\n                    In total, 889 observations from 570 participants were included. Four distinct classes were identified: (1) polysubstance use (PSU) and addiction treatment engagement; (2) PSU without treatment engagement; (3) exposure to unknown substances, mostly without treatment engagement; and (4) primary heroin users without treatment engagement. The class of exposure to unknown substances appeared in 2015 and became the dominant group (76.9%) in 2016. In multivariable analyses, the odds of membership in the class of primary heroin users decreased over time (adjusted odds ratio [AOR]: 0.74, 95% confidence interval [CI]: 0.68\u20130.81).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic toggle=\"yes\">Conclusions:<\/jats:italic>\n                    Changing profiles of PWUD reporting opioid-related NFOD were seen over time. Notably, there was a sudden increase in reports of overdose following exposure to unknown substances since 2015, the majority of whom reported no recent addiction treatment engagement. Further study into patterns of substance use and strategies to improve addiction treatment engagement is needed to improve and focus overdose prevention efforts.\n                  <\/jats:p>","DOI":"10.1080\/08897077.2019.1677280","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T13:56:24Z","timestamp":1588168584000},"page":"323-330","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Temporal Changes in Non-Fatal Opioid Overdose Patterns among People who use Drugs in a Canadian Setting"],"prefix":"10.1177","volume":"41","author":[{"given":"Christopher","family":"Fairgrieve","sequence":"first","affiliation":[{"name":"British Columbia Centre on Substance Use, St. Paul's Hospital, Vancouver, BC, Canada;"},{"name":"Department of Family Medicine, University of British Columbia, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Nosova","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, St. Paul's Hospital, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-J","family":"Milloy","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, St. Paul's Hospital, Vancouver, BC, Canada;"},{"name":"Department of Medicine, University of British Columbia, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Fairbairn","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, St. Paul's Hospital, Vancouver, BC, Canada;"},{"name":"Department of Medicine, University of British Columbia, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kora","family":"DeBeck","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, St. Paul's Hospital, Vancouver, BC, Canada;"},{"name":"School of Public Policy, Simon Fraser University, Burnaby, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Ahamad","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, St. Paul's Hospital, Vancouver, BC, Canada;"},{"name":"Department of Family Medicine, University of British Columbia, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Wood","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, St. Paul's Hospital, Vancouver, BC, Canada;"},{"name":"Department of Medicine, University of British Columbia, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, St. Paul's Hospital, Vancouver, BC, Canada;"},{"name":"Department of Medicine, University of British Columbia, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3843-2928","authenticated-orcid":false,"given":"Kanna","family":"Hayashi","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, St. Paul's Hospital, Vancouver, BC, Canada;"},{"name":"Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,7,1]]},"reference":[{"issue":"267","key":"e_1_3_4_2_2","first-page":"1","article-title":"Mortality in the United States","volume":"2016","author":"Xu J","year":"2015","unstructured":"Xu J, , Murphy SL, , Kochanek KD, , Arias E. Mortality in the United States. NCHS Data Brief. 2015;2016(267):1\u20138.","journal-title":"NCHS Data Brief."},{"key":"e_1_3_4_3_2","unstructured":"Office of the Chief Coroner British Columbia Coroners Service. Fentanyl-Detected Illicit Drug Overdose Deaths January 1 2012 to August 31 2017. https:\/\/www2.gov.bc.ca\/assets\/gov\/public-safety-and-emergency-services\/death-investigation\/statistical\/fentanyl-detected-overdose.pdf. Released October 12 2017. Accessed on November 5 2017."},{"issue":"39","key":"e_1_3_4_4_2","first-page":"849","article-title":"Increases in heroin overdose deaths - 28 States, 2010 to 2012","volume":"63","author":"Rudd RA","year":"2014","unstructured":"Rudd RA, , Paulozzi LJ, , Bauer MJ, . Increases in heroin overdose deaths - 28 States, 2010 to 2012. MMWR Morb Mortal Wkly Rep. 2014;63(39):849\u2013854.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"166","key":"e_1_3_4_5_2","first-page":"1","article-title":"Drug-poisoning deaths involving opioid analgesics: United States","volume":"2014","author":"Chen LH","year":"1999","unstructured":"Chen LH, , Hedegaard H, , Warner M. Drug-poisoning deaths involving opioid analgesics: United States. NCHS Data Brief. 1999\u20132011;2014(166):1\u20138.","journal-title":"NCHS Data Brief."},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.10.020"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00376.x"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.07.016"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62353-7"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/jtg022"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.13193"},{"key":"e_1_3_4_12_2","unstructured":"World Health Organization Regional Office for Europe. Prevention of acute drug-related mortality in prison populations during the immediate post-release period. Copenhagen 2010. ISBN 978 92 890 4204 8. http:\/\/www.rsat-tta.com\/Files\/Prison_Mortality.pdf. Released 2010. Accessed on June 9 2018."},{"issue":"2","key":"e_1_3_4_13_2","first-page":"CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"2","author":"Mattick RP","year":"2009","unstructured":"Mattick RP, , Breen C, , Kimber J, , Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009;2(2):CD002209.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"e_1_3_4_14_2","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"4","author":"Mattick RP","year":"2014","unstructured":"Mattick RP, , Breen C, , Kimber J, , Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;4(2):CD002207.","journal-title":"Cochrane Database Syst Rev."},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(01)00206-9"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2010.03.019"},{"key":"e_1_3_4_17_2","volume-title":"Illicit Drug Overdose Deaths in BC: January 1 -M, 2017.","author":"British Columbia Coroners Service","year":"2017","unstructured":"British Columbia Coroners Service. Illicit Drug Overdose Deaths in BC: January 1 -M, 2017. Burnaby, BC: Ministry of Public Safety & Solicitor General; 2017."},{"key":"e_1_3_4_18_2","unstructured":"Canadian Press. Opioid deaths in Canada expected to hit 4000 by end of 2017. https:\/\/www.cbc.ca\/news\/health\/opioid-deaths-canada-4000-projected-2017-1.4455518. Released December 19 2017. Accessed on February 5 2018."},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b1649"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.6.547"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-3-18"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/1536867X0700700205"},{"key":"e_1_3_4_23_2","unstructured":"R Development Core Team. R: A language and environment for statistical computing. Vienna Austria: R Found for Statistical Computing. https:\/\/www.R-project.org\/. 2016"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-015-0088-4"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.02.024"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6537a6"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-016-3137-3"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.15288\/jsad.2008.69.924"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.04.009"},{"key":"e_1_3_4_30_2","unstructured":"Wood EA Djurfors C . A Guideline for the clinical management of opioid addiction. http:\/\/www.bccsu.ca\/wp-content\/uploads\/2017\/06\/BC-OUD-Guidelines_June2017.pdf. Released June 5 2017. Accessed on July 20 2017."},{"key":"e_1_3_4_31_2","unstructured":"British Columbia Government News. B.C. expands access to recovery supports to combat overdose crisis. https:\/\/news.gov.bc.ca\/releases\/2017HLTH0008-000088. Released January 18 2017. Accessed on November 5 2017."},{"key":"e_1_3_4_32_2","unstructured":"Kim P. The overwhelming case for overdose prevention sites. http:\/\/www.pivotlegal.org\/the_overwhelming_case_for_overdose_prevention_sites: Pivot Legal Society 2017. Released December 14 2017. Accessed on May 3 2018."},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.13339"}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2019.1677280","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2019.1677280","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2019.1677280","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:08:24Z","timestamp":1780492104000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2019.1677280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1080\/08897077.2019.1677280"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2019.1677280","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}